Kieron Power

Principal Pharmacist - Thrombosis and Anticoagulation. Swansea Bay UHB. Views my own.

[BOPA Committee @BOPACommittee]

Registration is now open for the Cancer Associated Thrombosis Summit 2025!
Programme available here https://t.co/7L5Myp7oEh
The event takes place on Saturday 8th November 2025, 09.30 am – 4.30 pm at Canham Turner Building, University of Hull
Register: https://t.co/vFs3HnAEOC

[Kieron Power @power_kieron]

Proud to have our work on improving DVT pathways in Swansea Bay recognised and awarded the commended prize @ThrombosisUK awards 2025 @PharmacySBU

[Kieron Power @power_kieron]

At the @ThrombosisUK awards 2025 shortlisted for our work with our DVT pathway @PharmacySBU @SwanseabayNHS

[Kieron Power @power_kieron]

Thanks to @BPSA for asking me to speak today at their annual conference. A pleasure. And a really engaged and passionate audience of pharmacy students @PharmacySBU

[Kieron Power @power_kieron]

Another successful NEONC-CAT conference done and dusted. Great speakers finished with an enthusiastic debate around the validity of FXi inhibitors. See you all next year

[Kieron Power @power_kieron]

Thanks again to @BOPACommittee for inviting me to speak on cancer associated thrombosis. Always a pleasure and an impressive conference. Especially apt with #worldthrombosisday tomorrow

[BOPA Committee @BOPACommittee]

Next up is our breakouts sessions
Breakout 1, Room 9 #Gynaecological - Shabnam Sobhdam
Breakout 2 - Room 10 #Thrombosis @power_kieron
Breakout 3 Room 11A -Developments on #PharmacyTechnician screening -Claire Kennedy
Breakout 4 Room 11B #Research in #Pharmacy @rogfds
#BOPA2024

[Kieron Power @power_kieron]

Thrilled to have had the opportunity to present our work on our pharmacy-led VTE service at this years @PDaHW @PharmacySBU

[Royal College of Pharmacy Wales 🏴󠁧󠁢󠁷󠁬󠁳󠁿 @rcpharm_Wales]

Another great ‘trailblazer’ session at our @PDaHW Conference - hearing how pharmacy teams who are driving us towards our 2030 vision.

4 brilliant talks on ‘Kidsmedz Cymru’, thrombosis & anticoagulation, diabetes medicines optimisation & technician roles in elective orthopaedics.

[Royal College of Pharmacy Wales 🏴󠁧󠁢󠁷󠁬󠁳󠁿 @rcpharm_Wales]

Another great ‘trailblazer’ session at our @PDaHW Conference - hearing how pharmacy teams who are driving us towards our 2030 vision.

4 brilliant talks on ‘Kidsmedz Cymru’, thrombosis & anticoagulation, diabetes medicines optimisation & technician roles in elective orthopaedics.

[Kieron Power @power_kieron]

2/ Don’t miss out on this unique conference for clinicians interested in CAT, or those who want to know more about the condition

[Kieron Power @power_kieron]

1/🥁🥁🥁The Second Annual Cancer Associated Thrombosis Conference 2024. 01/11/24 at University of Hull.

Agenda> https://t.co/SXblT8BfCj

Registration > https://t.co/vaixv0IayU

[Christine Clark @ChristineCIark]

“Anecdotal feedback from patients suggests that those who have gone through the ambulatory pathway tend to be less anxious.”

Kieron Power explains how a fully-funded, sustainable, pharmacy-led PE pathway has been established. @power_kieron

[Christine Clark @ChristineCIark]

“Some registrars and other junior doctors have sat in on pharmacists’ clinics – an experience that …. has been mutually beneficial.”

Kieron Power explains how a fully-funded, sustainable, pharmacy-led PE pathway has been established. @power_kieron

[Christine Clark @ChristineCIark]

“89 were managed as ambulatory patients and the 30-day readmission rate was 4%”

Kieron Power describes the how the PE pathway allowed people with low-risk PEs to be treated safely as outpatients @power_kieron

[Christine Clark @ChristineCIark]

“I was very keen for us as pharmacists to focus on what I feel our skills are – which is fundamentally in therapeutics”

Kieron Power describes the how the PE pathway allowed people with low-risk PEs to be treated safely as outpatients @power_kieron

[Christine Clark @ChristineCIark]

“Part of the follow-up process involves checking for a cause of the initial VTE and screening for long-term complications.”

Kieron Power explains how the PE pathway works for both high- and low-risk PEs @power_kieron

[Christine Clark @ChristineCIark]

“We utilised our pharmacist-led VTE service to undertake those seven-day reviews”

Kieron Power explains how the PE pathway works for both high- and low-risk PEs @power_kieron

[Christine Clark @ChristineCIark]

“It’s critical that when we discharge a patient from hospital with a PE they are aware of what a bad outcome or complication can look like”

Kieron Power describes key steps in the care of pulmonary embolism patients @power_kieron

[Christine Clark @ChristineCIark]

“Follow-up is important because … we need to see how patients are recovering and make decisions around long-term management”

Kieron Power describes key steps in the care of pulmonary embolism patients @power_kieron

[MedicalUpdateOnline @MedUpdateOn1ine]

Pulmonary embolism – what patients experience https://t.co/8IMYhBlsa4

[Christine Clark @ChristineCIark]

“What we’ve started to realise …. is that not all PEs are the same and actually there’s distinct groups”

Kieron Power explains why some pulmonary embolism patients can be treated as outpatients. @power_kieron